MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT
Clinical trial NCT02931929 · COMPLETED
Trial details
- NCT number
- NCT02931929
- Sponsor
- Medical University Innsbruck
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2019-04-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.